The 2,5 Oligoadenylate Synthetase/RNaseL pathway is a novel effector of BRCA1 - and interferon-gamma-mediated apoptosis


Autoria(s): Mullan, Paul; Kennedy, R.; Buckley, Niamh; O'Brien, J.; Hosey, Alison; Johnston, Patrick; Harkin, Paul
Data(s)

18/08/2005

Resumo

I discovered that 2,5OAS family of proteins was transcriptionally upregulated by BRCA1 and interferon gamma in a synergistic manner. This correlated with synergistically induced apoptosis and both the induction of 2,5OAS and the accompanying apoptosis could be inhibited by 2,5OAS specific siRNA proving 2,5OAS was the apoptotic effector.

Identificador

http://pure.qub.ac.uk/portal/en/publications/the-25-oligoadenylate-synthetasernasel-pathway-is-a-novel-effector-of-brca1--and-interferongammamediated-apoptosis(378611f1-151a-4c9c-8cba-8898e120b673).html

http://dx.doi.org/10.1038/sj.onc.1208698

http://www.scopus.com/inward/record.url?scp=24644522875&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Mullan , P , Kennedy , R , Buckley , N , O'Brien , J , Hosey , A , Johnston , P & Harkin , P 2005 , ' The 2,5 Oligoadenylate Synthetase/RNaseL pathway is a novel effector of BRCA1 - and interferon-gamma-mediated apoptosis ' Oncogene , vol 24(35) , no. 35 , pp. 5492-5501 . DOI: 10.1038/sj.onc.1208698

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/1300/1311 #Genetics #/dk/atira/pure/subjectarea/asjc/1300/1312 #Molecular Biology
Tipo

article